Product Information
EVOXAC 30 MG CAPSULE is a brand product labeled by Cosette Pharmaceuticals, Inc., priced at $7.8170 per EA under NDC 00713088301. Its NADAC has been published 67 times since Mar 19, 2025.
The High Outlier badge above means this manufacturer's average price in the cevimeline hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
30 mg/1
Manufacturer
Cosette Pharmaceuticals, Inc.NDC
00713088301
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CEVIMELINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA020989On Market Since
9/1/2022
Pharmacological Classes
Price Statistics
The NADAC for EVOXAC 30 MG CAPSULE has been published 67 times since Mar 19, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.8170 per EA |
|---|---|
| All-time high | $7.8322 (Jan 14, 2026) |
| All-time low | $7.7614 (Sep 17, 2025) |
| 52-week high | $7.8322 |
| 52-week low | $7.7614 |
| Median price | $7.8081 |
| Average price | $7.8038 |
| Largest weekly change | +0.6% (Oct 22, 2025) |
| Weeks tracked | 67 |
| Tracking since | Mar 19, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 91% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EVOXAC 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for EVOXAC 30 MG CAPSULE, manufactured by Cosette Pharmaceuticals, Inc., is $7.8170 per EA (NDC 00713088301), effective Jun 24, 2026.
How has the price of EVOXAC 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for EVOXAC 30 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 67 weekly CMS publications since Mar 19, 2025.
What are the highest and lowest recorded NADAC prices for EVOXAC 30 MG CAPSULE?
Since Mar 19, 2025, the NADAC for EVOXAC 30 MG CAPSULE has ranged from a low of $7.7614 (Sep 17, 2025) to a high of $7.8322 (Jan 14, 2026), with a median of $7.8081 per EA.
Are there cheaper alternatives to EVOXAC 30 MG CAPSULE?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, CEVIMELINE HCL 30 MG CAPSULE, is $0.6871 per EA — about 91% below EVOXAC 30 MG CAPSULE.
Who manufactures EVOXAC 30 MG CAPSULE?
EVOXAC 30 MG CAPSULE (NDC 00713088301) is labeled by Cosette Pharmaceuticals, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification